Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Notes Payables (2016 - 2021)

STRATA Skin Sciences' Notes Payables history spans 7 years, with the latest figure at $7.3 million for Q2 2021.

  • For Q2 2021, Notes Payables changed 0.0% year-over-year to $7.3 million; the TTM value through Jun 2021 reached $7.3 million, changed 0.0%, while the annual FY2020 figure was $7.3 million, 0.0% changed from the prior year.
  • Notes Payables for Q2 2021 was $7.3 million at STRATA Skin Sciences, roughly flat from $7.3 million in the prior quarter.
  • Across five years, Notes Payables topped out at $7.3 million in Q4 2019 and bottomed at $34000.0 in Q3 2017.
  • The 5-year median for Notes Payables is $7.3 million (2019), against an average of $4.0 million.
  • The largest annual shift saw Notes Payables surged 47.31% in 2017 before it crashed 62.77% in 2018.
  • A 5-year view of Notes Payables shows it stood at $357000.0 in 2017, then crashed by 85.71% to $51000.0 in 2018, then surged by 14164.71% to $7.3 million in 2019, then changed by 0.0% to $7.3 million in 2020, then changed by 0.0% to $7.3 million in 2021.
  • Per Business Quant, the three most recent readings for SSKN's Notes Payables are $7.3 million (Q2 2021), $7.3 million (Q1 2021), and $7.3 million (Q4 2020).